Why the study?
Is ARFI elastography useful for quantifying fibrosis in chronic diffuse disease of the liver and kidney?
Is ARFI elastography useful for quantifying fibrosis in chronic diffuse disease of the liver and kidney?
ARFI elastography is a useful imaging modality for quantifying fibrosis in chronic diffuse diseases of the liver and kidney.
• Stiffness significantly varies among normal and abnormal biological tissues. • In clinical applications physical, geometrical, anatomical and physiological factors influence the SWV. • Elastographic techniques can quantify fibrosis, which is directly related to stiffness. • ARFI can be useful in chronic diffuse disease of liver and kidney.
No takes yet. Share an insight, caveat, or question.
Bruno et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: